companies making glp 1 drugs Market Overview: GLP-1 Agonists and the Obesity Market | Blog 2025’s Breakthrough GLP-1 Obesity Treatments:

Starting Wednesday, Medicare will help pay for some GLP-1 medications for weight loss

Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year.

Participants Patients with type 2 diabetes

Its important to talk with a healthcare provider about how long to use these medicines and make long-term healthy lifestyle changes to help keep weight off for good.What are the side effects?Common side effects include nausea, vomiting, diarrhea, abdominal pain, or constipation

But theres a tradeoff

Indication expansion, such as approvals for additional metabolic and cardiovascular conditions, is broadening patient access and driving adoption